NMDA glutamate receptors have key roles in brain development, function and dysfunction. Regulatory roles of D-serine in NMDA receptor-mediated synaptic plasticity have been reported. Nonetheless, it is unclear whether and how neonatal deficits in NMDA-receptor-mediated neurotransmission affect adult brain functions and behavior. Likewise, the role of D-serine during development remains elusive. Here we report behavioral and electrophysiological deficits associated with the frontal cortex in Pick1 knockout mice, which show D-serine deficits in a neonatal-and forebrain-specific manner. The pathological manifestations observed in adult Pick1 mice are rescued by transient neonatal supplementation of D-serine, but not by a similar treatment in adulthood. These results indicate a role for D-serine in neurodevelopment and provide novel insights on how we interpret data of psychiatric genetics, indicating the involvement of genes associated with D-serine synthesis and degradation, as well as how we consider animal models with neonatal application of NMDA receptor antagonists.
INTRODUCTION
NMDA glutamate receptors mediate excitatory neurotransmission and synaptic plasticity, and their modulation by endogenous factors has a critical role in these phenomena. Specifically, NMDA receptors are required for long-term potentiation and long-term depression, cellular processes of neural plasticity that underlie learning and memory. 1, 2 NMDA receptors are activated by glutamate and require several co-agonists, including D-serine. 3 A crucial role of D-serine in neural plasticity has also been demonstrated. [4] [5] [6] On the other hand, excess NMDA-receptormediated signaling can lead to excitotoxicity, which may underlie many brain disorders, including stroke, Alzheimer's disease, Huntington's disease and amyotrophic lateral sclerosis. 7-10 D-serine is also known to have a role in this toxic cascade in a context-dependent manner, including in some cases of stroke and amyotrophic lateral sclerosis. [11] [12] [13] During brain development, NMDA receptors are crucial for the generation of spontaneous synchronous network activity in the neonatal brain. [14] [15] [16] [17] NMDA receptors are also essential for the conversion of silent to active synapses by recruiting AMPA receptors. 18 However, it is unclear whether and how neonatal deficits in NMDA-receptor-mediated neurotransmission affect adult brain functions and behavior. Likewise, the role of D-serine during development remains elusive. Given that NMDA receptors are modulated by D-serine, animal models with transient deficits in D-serine during neonatal stages may provide a good tool to address this question.
PICK1 is a multifunctional scaffold protein that interacts with many proteins, including several types of glutamate receptors and serine racemase, the D-serine-synthesizing enzyme. 19, 20 PICK1 has been extensively studied in the context of neural plasticity, [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] and mice deficient in Pick1 are also available. 22 Nonetheless, the physiological role of PICK1-serine racemase protein interactions remain elusive. In cell cultures, PICK1 can augment the enzymatic activity of serine racemase and D-serine synthesis. 21 Pick1 knockout mice display a significant reduction in D-serine levels, which is specific to the forebrain during the neonatal stage: the level of D-serine is normal in adult Pick1 mice. 21 Here we aimed to address the significance of D-serine in brain development on adult brain function and behavior, by using Pick1 knockout mice. As the first step, we examined behavioral and electrophysiological characteristics associated with the frontal cortex of the Pick1 mice. We then tested whether the representative deficits in adulthood are normalized by transiently supplying D-serine only during the neonatal stage. neural plasticity. 23, 24 For all groups, pups were weaned on postnatal day 21, genotyped and housed in sex-matched groups of five in standard mouse cages in accordance with protocols approved by the Johns Hopkins University, the University of Maryland and the RIKEN Animal Care and Use Committees.
Behavioral tests
Behavioral tests were conducted on male Pick1 knockout mice and control littermates in adulthood (42 months of age), with a 1-week interval between tests. We conducted the assays based on our published protocols with minor modifications. [33] [34] [35] [36] [37] [38] [39] Open field test. Horizontal and vertical locomotor activity were assessed for 2 h using activity chambers equipped with infrared beams (San Diego Instruments, San Diego, CA, USA). Horizontal and vertical movements, stereotypies and time spent in the center or along the walls of the chamber (thigmotaxis) were automatically recorded.
PPI of the acoustic startle. The prepulse inhibition (PPI) test was performed as previously described. 34, 39 Two identical startle chambers (San Diego Instruments) were used for measuring startle reactivity. During each PPI session, a mouse was exposed to the following types of trials: pulse alone (a 120 dB, 100 ms, broadband burst); the omission of stimuli (no-stimulus trial); and four prepulse-pulse combinations (prepulse-pulse trials) consisting of a 20-ms broadband burst used as a prepulse and presented 80 ms before the pulse using one of the five prepulse intensities (74, 78, 82, 86 and 90 dB). Each session consisted of six presentations of each type of trial presented in a pseudorandom order. The background noise presented throughout the entire session was 70 dB.
Forced swim test. The forced swim test was employed to evaluate depression-associated responses. Latency to immobility and total immobility were analyzed during the last 4 min of the 6 min test using the SMART program (San Diego Instruments).
Elevated plus maze. The elevated plus maze was used to assess anxiety as described previously. 34 Y-maze. Spontaneous alternation as a measure of spatial working memory was assessed in the Y-maze. The spontaneous alternation behavior was calculated as the number of triads (visiting three different arms on consecutive choices, for example, ABC, but not ABB or ACC) divided by the total number of arms entered minus two. 40 Quantitative real-time PCR Quantitative real-time PCR was performed by the ABI Prism 7900HT sequence detection system (Applied Biosystems, Foster City, CA, USA). Note, we performed this molecular study with frontal cortex homogenates from mice that had been injected with saline for another assay. The primers used for the study were as follows: Neonatal or adult D-serine treatment D-serine (500 mg kg − 1 ; Sigma-Aldrich, St Louis, MO, USA) was dissolved in sterile physiological saline and administered i.p., using a 30-gauge needle, every day for 2 weeks beginning on postnatal day 3. The dose was chosen according to a representative publication, which showed that 300-900 mg kg − 1 of D-serine ameliorated a PPI deficit induced by dizocilpine in adult mice. 42 The effects of D-serine were evaluated in adulthood using the PPI and Y-maze tests and electrophysiological recordings assessing NMDA modulation of pyramidal cell firing in prefrontal cortical slices.
Since it was a control experiment, the conditions of the adult D-serine treatment were the same as the neonatal treatment (500 mg kg − 1 i.p daily for 2 weeks) except for the timing: it started at the age of 8 weeks. After 2 weeks of treatment we waited 1 week to avoid acute effects of the D-serine and then did either electrophysiology or behavioral testing (Y-maze followed by PPI after another 1-week interval).
Statistical analysis
Statistical analysis was performed by analysis of variance (ANOVA). A student's t-test was used to compare two sets of data. Values in graphs are expressed as the mean plus the s.e.m. Significance levels are marked as follows: *Po0.05.
RESULTS

Behavioral and molecular alterations in adult Pick1 knockout mice
We analyzed the behavioral consequences of deleting the Pick1 gene by performing behavioral tests relevant to diverse aspects of mental conditions. Pick1 knockout mice did not differ from wildtype littermates in open field activity over 2 h (Supplementary Figure 1 ), but when we divided the 2 h into four bins of 30 min, we found them to be significantly hyperactive during the 60-90-min interval (Figure 1a, Supplementary Figure 1 ). The hyperactivity of Pick1 knockout mice was unlikely related to altered emotionality, as no significant group differences were seen in the elevated plus maze and the forced swim test (Figures 1b and c, Supplementary Figure 2 ). We also assessed PPI of the acoustic startle response, a measure of sensorimotor gating, which is reportedly impaired in patients with several neuropsychiatric disorders, including schizophrenia ( Figure 1d ). 43 Two-way repeated measures ANOVA showed a significant group effect-F(1,89) = 6.04, P = 0.026 and significant group by prepulse interaction-F(4,89) = 6.21, P o0.001. Post-hoc tests demonstrated that, compared with controls, knockouts had significantly decreased PPI at the prepulse intensities of 74, 78 and 82 dB. Notably, Pick1 knockout mice showed an increase in startle response, indicating that impaired PPI was not due to insufficient startle response ( Supplementary  Figure 3 ). In addition, Pick1 knockout mice also exhibited significantly fewer spontaneous alternations in the Y-maze compared with wild-type mice (Figure 1e ), which is a sign of working memory deficit. 43, 44 Abnormalities in PPI and working memory could result from deficits of the prefrontal cortex. 45 We also conducted an exploratory expression study for candidate molecules (AMPA receptor regulator Stargazin and interneuron markers of Parvalbumin and Gad67): real-time PCR indicated an increase in the expression of Stargazin and Parvalbumin, but not that of Gad67, in adult Pick1 knockout mice ( Supplementary Figure 4) .
Alterations in NMDA-elicited firing of prefrontal cortical pyramidal neurons in adult Pick1 knockout mice As behavioral deficits in Pick1 mice suggested altered prefrontal cortical function, we hypothesized that pyramidal neurons in the prefrontal cortex of Pick1 knockout mice may display altered physiological properties. To address this question, we tested the excitability of pyramidal neurons in brain slices containing the prefrontal cortex of adult Pick1 knockout mice and wild-type littermates. The number of action potentials evoked with intracellular current injections before and after bath application of NMDA (4 μM) was examined as a readout of cell excitability (Figure 2 , Supplementary Table 1 ). We also tested whether the modulation of NMDA responses by D1 dopamine receptors is affected in Pick1 knockout mice by adding the selective D1 agonist SKF38393 (2 μM). 41 The resting membrane potential was not different between wild-type and Pick1 knockout mice, and was not affected by the addition of NMDA and SKF38393 (wild-type: − 63.3 ± 1.5 mV at baseline, − 62.0 ± 2.2 mV with NMDA, − 60.3 ± 3.6 mV with NMDA and SKF38393; Pick1 knockout mice: − 65.8 ± 3.1 mV at baseline, − 63.5 ± 3.1 mV with NMDA, − 62.0 ± 5.7 mV with NMDA and SKF38393). Thus, basic membrane properties of prefrontal pyramidal neurons were not affected in Pick1 knockout mice.
We then tested whether Pick1 knockout mice exhibited altered modulation of excitability by NMDA in pyramidal neurons. The number of action potentials evoked by a constant-amplitude Role for neonatal D-serine current pulse was markedly increased by application of NMDA in wild-type mice (from 6.6 ± 0.5-11.4 ± 2.8 spikes; a 73% increase from baseline) (Figure 2 , Supplementary Table 1 ). Although the D1 agonist SKF38393 alone did not change the number of action potentials, the combined addition of NMDA and SKF38393 synergistically augmented the number of action potentials (to 13.1 ± 4.8; a 101% increase from baseline) in wild-type mice. In Pick1 knockout mice, however, the increase in the number of action potentials by NMDA was significantly attenuated (from 5.8 ± 1.7 to 7.8 ± 2.3; a 33% increase from baseline), and the addition of SKF38393 to NMDA only slightly elevated the response (to 8.5 ± 3.4; a 45% increase from baseline). A two-way ANOVA with genotype and drug treatment as factors revealed genotype differences (ANOVA F 1,22 = 5.82, P = 0.024), indicating that NMDA responses are impaired in Pick1 knockout mice. There was no significant interaction between genotype and D1 agonist treatment (P = 0.914), indicating that D1 modulation of NMDA responses was not affected in Pick1 knockout mice.
Influence of neonatal D-serine on behavioral defects in adult Pick1
knockout mice Here we show that Pick1 knockout mice have prefrontal cortexassociated behavioral deficits in adulthood. Which mechanism(s) underlie these deficits? One possibility is that downregulation of D-serine during development, at the neonatal stage, may contribute to these adult deficits in Pick1 knockout mice. To address this question, we administered D-serine (500 mg kg − 1 , i.p.) daily to pups beginning on postnatal day 3 for 2 weeks, and then maintained the animals until adulthood without any further supplementation of D-serine ( Figure 3 ). We did not observe any adverse effects of neonatal injections (data not shown). We evaluated the effects of this neonatal treatment with D-serine by monitoring possible improvement in PPI and spontaneous alternations in the Y-maze in adult mice. Compared with saline treatment, D-serine treatment in the neonatal stage significantly increased the PPI in Pick1 knockout, but not in wild-type mice (Figure 4 ). We assessed the PPI effects separately for Pick1 knockout mice and wild-type mice, as our pilot data had not revealed effects of D-serine on wild-types; this design increases the power of analysis. Two-way repeated measures ANOVA of the data for knockout mice revealed a significant effect of treatment, F(1,99) = 4.8, P = 0.041, but not for wild-type mice, F(1,64) = 0.6, P = 0.47. A trend of beneficial effect of neonatal D-serine treatment was also seen in the adult behaviors in Y-maze (Supplementary Figure 5 ). Note, due to unexpected baseline changes elicited by neonatal injection itself, this statement on Y-maze is not conclusive. We also tested the impact of adult D-serine administration (500 mg kg − 1 , i.p.; daily beginning at the age of 8 weeks for 2 weeks) on these behaviors. In regard to PPI, we cannot make any meaningful statements because repeated injections in adulthood significantly altered the baseline response in both wild-type and knockout mice (Supplementary Figure 6A) . Meanwhile, we observed conclusive evidence that adult D-serine treatment did not rescue the deficit in spontaneous alternations in Pick1 knockout mice (Supplementary Figure 6B) .
Influence of neonatal D-serine on electrophysiological defects in adult Pick1 knockout mice
We next addressed whether neonatal D-serine treatment of Pick1 knockout mice may normalize the electrophysiological deficits observed in adult mice. We prepared prefrontal cortical slices from D-serine-treated Pick1 knockout mice, and conducted electrophysiological assessments similar to those presented in Figure 2 . The resting membrane potentials of Pick1 knockout mice treated with D-serine during the neonatal period and adulthood were − 66.6 ± 4.7 mV and − 67.9 ± 3.1 mV, respectively. Unlike untreated Pick1 knockout mice, NMDA (4 μM) elicited strong increases in evoked action potential firing in slices from D-serine-treated Pick1 knockout mice. The number of action potentials evoked by current injection rose from 3.9 ± 1.2 to 7.4 ± 3.2 with NMDA administration (89% increase from baseline; Figure 5a , Supplementary Table 1 ). The addition of SKF38393 to NMDA slightly increased the number of action potentials to 8.9 ± 3.6. A two-way ANOVA revealed differences between treated and untreated Pick1 knockout mice (F 1,22 = 7.91, P = 0.010). These results indicate that D-serine treatment during development rescued adult NMDA function in Pick1 knockout mice.
In contrast, when we conducted D-serine treatment in adulthood, responses of neurons were noticeably blunted in Pick1 knockout mice: to NMDA (5.7 ± 1.7 at baseline to 8.2 ± 3.2 spikes for a 46% increase in action potential firing) or NMDA plus SKF38393 (9.7 ± 3.6, a 70% increase from baseline) (Figure 5b , Supplementary Table 1 ). To statistically confirm the contrastive responses between neonatal and adult D-serine treatment to Pick1 mice, we employed a two-way ANOVA. First, a significant effect of D-serine treatment (F 2,42 = 7.502, P = 0.002) was revealed in Pick1 mice. Second, post-hoc comparisons using Tukey's HSD indicate that neonatal treatment rescued the electrophysiological deficits in untreated Pick1 mice (P = 0.002), whereas this rescue was absent on treatment in adulthood (P = 0.52). Thus, we conclude that neonatal, but not adult, D-serine treatment rescues NMDA function in adult Pick1 knockout mice.
DISCUSSION
It has been an unanswered question whether D-serine during brain development has a role in adult brain function and behavior, although its physiological and pathological role in adult animals have been well studied. 6, 42, [46] [47] [48] [49] To address this question, here we utilized Pick1 knockout mice in which the D-serine level is selectively reduced in the forebrain only during the neonatal stage. 21 Adult Pick1 knockout mice showed several behavioral abnormalities and electrophysiological deficits in the prefrontal cortex. Importantly, neonatal, but not adult, D-serine supplement rescued such adult deficits. These observations suggest a novel role for D-serine during brain development, with significant influence on adult brain function and behavior.
How does altered D-serine during development affect adult performance? The most probable scenario is that neonatal D-serine influences NMDA receptors, which in turn affects brain network formation. In Pick1 knockout mice, a neonatal-specific deficit in D-serine may lead to transient hypo-NMDA function during a critical period for proper brain development. Alternatively, D-serine may influence brain development by an unknown mechanism independent of its action on NMDA receptors. The next question, although it is beyond the scope of the present study, is to characterize how neonatal D-serine administration to Pick1 knockout mice may change (possibly normalize) neural network formation during the developmental trajectory, in comparison with non-treated Pick1 knockout and wild-type mice. We have previously published that Pick1 knockout mice have reduced D-serine levels at P7 (neonatal stage), but not in adulthood (P56). 21 Based on those results, here we tested whether supplementation of D-serine during the neonatal period (P3-P17) would improve behavioral and electrophysiological deficits seen in adulthood and indeed it did.
As a control experiment we also treated the mice with D-serine in adulthood (P56-P70), followed by a washout period of 1 week, and found no effect on behavior or electrophysiology. P, postnatal day.
Role for neonatal D-serine By comparing these data with those from mice with direct genetic modulation of NMDA receptors, we may be able to clarify whether the effects of neonatal D-serine supply are via NMDA receptors. Acute or sub-chronic administration of phencyclidine, a NMDA receptor antagonist, to rodents can produce behaviors resembling phenomena observed in schizophrenia. 50 Clinical observation of phencyclidine-induced psychosis and schizophrenia-like manifestation in normal subjects with non-competing NMDA receptor antagonists indicate a possible role of adult NMDA neurotransmission in the disease. [51] [52] [53] The current view on the mechanisms by which NMDA antagonists may produce psychosis relates to their ability to selectively suppress local inhibitory processes yielding cortical disinhibition and these effects are evident in adolescents and adults. 54 Thus, the mechanism leading to behavioral deficits in Pick1 knockout mice is different from those elicited by adult and adolescent administration of NMDA receptor antagonists that functionally impair glutamatergic neurotransmission. 55 Instead, as discussed above, neonatal D-serine and NMDA receptors are likely to influence neural circuit formation during neurodevelopment, secondarily affecting adult brain function and behavior in neonatal manipulations that reduce NMDA receptor activity. Thus, neonatal administration of phencyclidine may be a useful model for adult mental illnesses, [56] [57] [58] [59] but is justified in the context of neurodevelopment, distinct from models with adult and adolescent administration of NMDA receptor antagonists.
As PICK1 is a multifunctional protein, the phenotypes of Pick1 knockout mice reflect not only D-serine associated abnormalities but also deficits elicited by many other mechanisms. Thus, in the present study, we conducted neonatal supplement of D-serine to address the primary cause of D-serine. Nonetheless, one may wonder why we did not use conditional knockout mice lacking serine racemase, 60 the synthesizing enzyme for D-serine, for this study. This is in part because we currently do not have access to the conditional mice. Furthermore, as Serine racemase generates not only D-serine but also pyruvate, keto-acid and ammonia, 61 its knockout may not be a tool to purely address the role for D-serine. Thus, both conditional serine racemase knockout and Pick1 knockout mice are complementary towards investigating the neonatal role for D-serine.
Genetic studies have suggested that genes encoding key molecules of D-serine synthesis, degradation and regulation (for example, D-amino acid oxidase, serine racemase and possibly G72) are frequently associated with bipolar disorder and schizophrenia. [62] [63] [64] A recent genome wide association study has indicated 108 chromosomal loci that associate with schizophrenia, which include the locus of the serine racemase gene. 65 In addition, a chromosomal abnormality associated with schizophrenia is reportedly linked to downregulation of phosphoserine amino-transferase1, PSAT1, a key enzyme for the synthesis of L-serine, the precursor of D-serine. 69 Some studies have found reduced D-serine in the cerebrospinal fluid of patients with schizophrenia, 66, 67 whereas, other studies including a meta-analysis found no differences. 68 Accordingly, the Pick1 knockout mice with D-serine deficit specific to neonatal stage may model schizophrenia in which adult D-serine level is normal.
Thus far, NMDA hypofunction has been modeled primarily using experimental animals, which include the serine racemase knockout mice in which D-serine deficiencies are present throughout life. The Pick1 knockout model offers a unique opportunity to investigate the role of D-serine deficiency limited to the neonatal stage for behavior during adulthood. Our findings demonstrate that neonatal D-serine deficiency, on its own, is sufficient to induce some behavioral phenotypes, such as impaired PPI and spontaneous alternation that may serve as pathophysiological markers for schizophrenia or other major mental disorders, and that such effects are rescued by neonatal D-serine treatment. Future studies are needed to determine the relative importance of neonatal vs adult D-serine deficiency in the pathology of major mental illness.
